The ratio of peripheral regulatory T cells to Lox-1                         1                          polymorphonuclear myeloid-derived suppressor cells predicts the early response to Anti–PD-1 therapy in patients with non–small cell lung cancer

Hye Ryun Kim; Su Myeong Park; Sang Uk Seo; Inkyung Jung; Hong In Yoon; Dmitry I. Gabrilovich; Byoung Chul Cho; Seung Yong Seong; Sang Jun Ha; Je In Youn

doi:10.1164/rccm.201808-1502LE

The ratio of peripheral regulatory T cells to Lox-1 ¹ polymorphonuclear myeloid-derived suppressor cells predicts the early response to Anti–PD-1 therapy in patients with non–small cell lung cancer

Hye Ryun Kim
, Su Myeong Park
, Sang Uk Seo
, Inkyung Jung
, Hong In Yoon
, Dmitry I. Gabrilovich
, Byoung Chul Cho
, Seung Yong Seong
, Sang Jun Ha
, Je In Youn

Department of Microbiology

Research output: Contribution to journal › Letter › peer-review

94 Scopus citations

Original language	English
Pages (from-to)	243-246
Number of pages	4
Journal	American Journal of Respiratory and Critical Care Medicine
Volume	199
Issue number	2
DOIs	https://doi.org/10.1164/rccm.201808-1502LE
State	Published - 15 Jan 2019

Bibliographical note

Funding Information:
Supported by grants from the Basic Science Research Program through the National Research Foundation of the Republic of Korea (2015R1C1A1A01054596, 2012R1A5A2A44671346, 2017R1D1A1B03029874, 2017R1A5A1014560, 2018M3A9H3024850, 2017M3A9E9072669, and 2017M3A9E8029717) and the Research Resettlement Fund for the New Faculty of Seoul National University.

Funding Information:
Supported by NIH grants R01HL125583 and R01HL130512, and by the Precision Medicine Initiative from the Department of Pathology of Brigham and Women’s Hospital, Boston, Massachusetts.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1164/rccm.201808-1502LE

Cite this

Kim, H. R., Park, S. M., Seo, S. U., Jung, I., Yoon, H. I., Gabrilovich, D. I., Cho, B. C., Seong, S. Y., Ha, S. J., & Youn, J. I. (2019). The ratio of peripheral regulatory T cells to Lox-1 ¹ polymorphonuclear myeloid-derived suppressor cells predicts the early response to Anti–PD-1 therapy in patients with non–small cell lung cancer American Journal of Respiratory and Critical Care Medicine, 199(2), 243-246. https://doi.org/10.1164/rccm.201808-1502LE

Kim, Hye Ryun ; Park, Su Myeong ; Seo, Sang Uk et al. / The ratio of peripheral regulatory T cells to Lox-1 ¹ polymorphonuclear myeloid-derived suppressor cells predicts the early response to Anti–PD-1 therapy in patients with non–small cell lung cancer In: American Journal of Respiratory and Critical Care Medicine. 2019 ; Vol. 199, No. 2. pp. 243-246.

@article{f867bde072ea47438dfdc3ee71c208f7,

title = " The ratio of peripheral regulatory T cells to Lox-1 1 polymorphonuclear myeloid-derived suppressor cells predicts the early response to Anti–PD-1 therapy in patients with non–small cell lung cancer ",

author = "Kim, \{Hye Ryun\} and Park, \{Su Myeong\} and Seo, \{Sang Uk\} and Inkyung Jung and Yoon, \{Hong In\} and Gabrilovich, \{Dmitry I.\} and Cho, \{Byoung Chul\} and Seong, \{Seung Yong\} and Ha, \{Sang Jun\} and Youn, \{Je In\}",

note = "Funding Information: Supported by grants from the Basic Science Research Program through the National Research Foundation of the Republic of Korea (2015R1C1A1A01054596, 2012R1A5A2A44671346, 2017R1D1A1B03029874, 2017R1A5A1014560, 2018M3A9H3024850, 2017M3A9E9072669, and 2017M3A9E8029717) and the Research Resettlement Fund for the New Faculty of Seoul National University. Funding Information: Supported by NIH grants R01HL125583 and R01HL130512, and by the Precision Medicine Initiative from the Department of Pathology of Brigham and Women{\textquoteright}s Hospital, Boston, Massachusetts.",

year = "2019",

month = jan,

day = "15",

doi = "10.1164/rccm.201808-1502LE",

language = "English",

volume = "199",

pages = "243--246",

journal = "American Journal of Respiratory and Critical Care Medicine",

issn = "1073-449X",

publisher = "American Thoracic Society",

number = "2",

}

Kim, HR, Park, SM, Seo, SU, Jung, I, Yoon, HI, Gabrilovich, DI, Cho, BC, Seong, SY, Ha, SJ & Youn, JI 2019, ' The ratio of peripheral regulatory T cells to Lox-1 ¹ polymorphonuclear myeloid-derived suppressor cells predicts the early response to Anti–PD-1 therapy in patients with non–small cell lung cancer ', American Journal of Respiratory and Critical Care Medicine, vol. 199, no. 2, pp. 243-246. https://doi.org/10.1164/rccm.201808-1502LE

The ratio of peripheral regulatory T cells to Lox-1 ¹ polymorphonuclear myeloid-derived suppressor cells predicts the early response to Anti–PD-1 therapy in patients with non–small cell lung cancer . / Kim, Hye Ryun; Park, Su Myeong; Seo, Sang Uk et al.
In: American Journal of Respiratory and Critical Care Medicine, Vol. 199, No. 2, 15.01.2019, p. 243-246.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - The ratio of peripheral regulatory T cells to Lox-1 1 polymorphonuclear myeloid-derived suppressor cells predicts the early response to Anti–PD-1 therapy in patients with non–small cell lung cancer

AU - Kim, Hye Ryun

AU - Park, Su Myeong

AU - Seo, Sang Uk

AU - Jung, Inkyung

AU - Yoon, Hong In

AU - Gabrilovich, Dmitry I.

AU - Cho, Byoung Chul

AU - Seong, Seung Yong

AU - Ha, Sang Jun

AU - Youn, Je In

N1 - Funding Information: Supported by grants from the Basic Science Research Program through the National Research Foundation of the Republic of Korea (2015R1C1A1A01054596, 2012R1A5A2A44671346, 2017R1D1A1B03029874, 2017R1A5A1014560, 2018M3A9H3024850, 2017M3A9E9072669, and 2017M3A9E8029717) and the Research Resettlement Fund for the New Faculty of Seoul National University. Funding Information: Supported by NIH grants R01HL125583 and R01HL130512, and by the Precision Medicine Initiative from the Department of Pathology of Brigham and Women’s Hospital, Boston, Massachusetts.

PY - 2019/1/15

Y1 - 2019/1/15

UR - https://www.scopus.com/pages/publications/85060016541

U2 - 10.1164/rccm.201808-1502LE

DO - 10.1164/rccm.201808-1502LE

M3 - Letter

C2 - 30339766

AN - SCOPUS:85060016541

SN - 1073-449X

VL - 199

SP - 243

EP - 246

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

IS - 2

ER -

Kim HR, Park SM, Seo SU, Jung I, Yoon HI, Gabrilovich DI et al. The ratio of peripheral regulatory T cells to Lox-1 ¹ polymorphonuclear myeloid-derived suppressor cells predicts the early response to Anti–PD-1 therapy in patients with non–small cell lung cancer American Journal of Respiratory and Critical Care Medicine. 2019 Jan 15;199(2):243-246. doi: 10.1164/rccm.201808-1502LE

The ratio of peripheral regulatory T cells to Lox-1 1 polymorphonuclear myeloid-derived suppressor cells predicts the early response to Anti–PD-1 therapy in patients with non–small cell lung cancer

Bibliographical note

UN SDGs

Access to Document

Other files and links

Cite this

The ratio of peripheral regulatory T cells to Lox-1 ¹ polymorphonuclear myeloid-derived suppressor cells predicts the early response to Anti–PD-1 therapy in patients with non–small cell lung cancer